Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms

J Comp Pathol. 2024 May:211:26-35. doi: 10.1016/j.jcpa.2024.04.001. Epub 2024 May 17.

Abstract

Melanocytic neoplasms originate from melanocytes and melanoma, the malignant form, is a common canine neoplasm and the most aggressive human skin cancer. Despite many similarities between these neoplasms in both species, only a limited number of studies have approached these entities in a comparative manner. Therefore, this review compares benign and malignant melanocytic neoplasms in dogs and humans, exclusively those arising in the haired skin, with regard to their clinicopathological, immunohistochemical and molecular aspects. Shared features include spontaneous occurrence, macroscopic features and microscopic findings when comparing human skin melanoma in the advanced/invasive stage and canine cutaneous melanoma, immunohistochemical markers and several histopathological prognostic factors. Differences include the apparent absence of active mutations in the BRAF gene in canine cutaneous melanoma and less aggressive clinical behaviour in dogs than in humans. Further studies are required to elucidate the aetiology and genetic development pathways of canine cutaneous melanocytic neoplasms. Evaluation of the applicability of histopathological prognostic parameters commonly used in humans for dogs are also needed. The similarities between the species and the recent findings regarding genetic mutations in canine cutaneous melanomas suggest the potential utility of dogs as a natural model for human melanomas that are not related to ultraviolet radiation.

Keywords: dogs; humans; immunohistochemistry; melanocytes; melanoma; prognosis; skin neoplasm.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor
  • Dog Diseases* / pathology
  • Dogs
  • Humans
  • Immunohistochemistry*
  • Melanoma* / pathology
  • Melanoma* / veterinary
  • Melanoma, Cutaneous Malignant
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / veterinary

Substances

  • Biomarkers, Tumor